Sulforaphane Supplementation in Atopic Asthmatics
Sulforaphane Supplementation in Atopic Asthmatics
NCT ID: NCT01845493 Phase: PHASE1 Status: COMPLETED Enrollment: 16 Completion: 2014-10
Conditions
Asthma
Interventions
Alpha Sprout Homogenate, Sulforaphane Homogenate
Summary
The investigators will perform a pilot study of daily treatment with oral sulforaphane (SFN) for 3 days to determine if Nuclear factor (erythroid-derived 2)-like 2 (NRF2) induction is possible with this supplementation regimen in individuals with allergic asthma.
Primary Outcome
mRNA levels of NRF2 and NRF2-dependent phase II enzymes in nasal epithelial cells